Literature DB >> 9314870

Effectiveness of clinical guidelines for the presumptive treatment of streptococcal pharyngitis in Egyptian children.

M C Steinhoff1, M K Abd el Khalek, N Khallaf, H S Hamza, A el Ayadi, A Orabi, H Fouad, M Kamel.   

Abstract

BACKGROUND: Primary prevention of acute rheumatic fever requires antibiotic treatment of acute streptococcal pharyngitis. In developing countries, clinicians must rely on clinical guidelines for presumptive treatment of streptococcal pharyngitis since bacterial culture and rapid diagnostic tests are not feasible. We evaluated the WHO Acute Respiratory Infection guideline in a large urban paediatric clinic in Egypt.
METHODS: Children between 2 and 13 years of age who had a sore throat and pharyngeal erythema were enrolled in the study. Clinical, historical, and demographic information was recorded and a throat culture for group A beta-haemolytic streptococci was done. Sensitivity (% of true-positive throat cultures) and specificity (% of true-negative throat cultures) were calculated for each clinical feature. The effect of various guidelines on correct presumptive treatment for throat-culture status was calculated.
FINDINGS: Of 451 children with pharyngitis, 107 (24%) had group A beta-haemolytic streptococci on throat culture. A purulent exudate was seen in 22% (99/450) of these children and this sign was 31% sensitive and 81% specific for a positive culture. The WHO Acute Respiratory Infections (ARI) guidelines, which suggest treatment for pharyngeal exudate plus enlarged and tender cervical node, were 12% sensitive and 94% specific; 13/107 children with a positive throat culture would correctly receive antibiotics and 323/344 with a negative throat culture would, correctly, not receive antibiotics. Based on our data we propose a modified guideline whereby exudate or large cervical nodes would indicate antibiotic treatment, and this guideline would be 84% sensitive and 40% specific; 90/107 children with a positive throat culture would correctly receive antibiotics and 138/344 with a negative throat culture would, correctly, not receive antibiotics.
INTERPRETATION: The WHO ARI clinical guideline has a high specificity but low sensitivity that limits the unnecessary use of antibiotics, but does not treat 88% of children with a positive streptococcal throat culture who are at risk of acute rheumatic fever. A modified guideline may be more useful in this population. Prospective studies of treatment guidelines from many regions are needed to assess their use since the frequency of pharyngitis varies.

Entities:  

Keywords:  Africa; Age Factors; Antibiotics--therapeutic use; Arab Countries; Bacterial And Fungal Diseases; Child; Demographic Factors; Developing Countries; Diseases; Drugs; Egypt; Examinations And Diagnoses--standards; Infections; International Agencies; Mediterranean Countries; Northern Africa; Organizations; Population; Population Characteristics; Research Report; Respiratory Infections; Rheumatic Fever--prevention and control; Signs And Symptoms; Treatment--standards; Un; Who; Youth

Mesh:

Substances:

Year:  1997        PMID: 9314870     DOI: 10.1016/s0140-6736(97)03317-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  23 in total

1.  What is the quality of drug therapy clinical practice guidelines in Canada?

Authors:  I D Graham; S Beardall; A O Carter; J Glennie; P C Hébert; J M Tetroe; F A McAlister; S Visentin; G M Anderson
Journal:  CMAJ       Date:  2001-07-24       Impact factor: 8.262

2.  The good use of plasma. A critical analysis of five international guidelines.

Authors:  Alfonso Iorio; Michela Basileo; Emanuela Marchesini; Mario Materazzi; Mauro Marchesi; Antonella Esposito; Gian Paolo Palazzesi; Lucio Pellegrini; Barbara Luciani Pasqua; Lauretta Rocchetti; Carla Maria Silvani
Journal:  Blood Transfus       Date:  2008-01       Impact factor: 3.443

3.  The Cape Town Clinical Decision Rule for Streptococcal Pharyngitis in Children.

Authors:  Mark E Engel; Karen Cohen; Ronald Gounden; Andre P Kengne; Dylan Dominic Barth; Andrew C Whitelaw; Veronica Francis; Motasim Badri; Annemie Stewart; James B Dale; Bongani M Mayosi; Gary Maartens
Journal:  Pediatr Infect Dis J       Date:  2017-03       Impact factor: 2.129

4.  Reducing uncertainty in managing respiratory tract infections in primary care.

Authors:  Naomi Stanton; Nick A Francis; Chris C Butler
Journal:  Br J Gen Pract       Date:  2010-12       Impact factor: 5.386

5.  Streptococcal pharyngitis in schoolchildren in Bamako, Mali.

Authors:  Milagritos D Tapia; Samba O Sow; Boubou Tamboura; Mahamadou M Keita; Abdoulaye Berthe; Mariam Samake; James P Nataro; Uma O Onwuchekwa; Thomas A Penfound; William Blackwelder; James B Dale; Karen L Kotloff
Journal:  Pediatr Infect Dis J       Date:  2015-05       Impact factor: 2.129

Review 6.  Addressing the burden of group A streptococcal disease in India.

Authors:  Anita Shet; Edward Kaplan
Journal:  Indian J Pediatr       Date:  2004-01       Impact factor: 1.967

Review 7.  Update on the management of acute pharyngitis in children.

Authors:  Marta Regoli; Elena Chiappini; Francesca Bonsignori; Luisa Galli; Maurizio de Martino
Journal:  Ital J Pediatr       Date:  2011-01-31       Impact factor: 2.638

8.  Rapid Detection and Diagnosis of Group A Streptococcal Pharyngitis.

Authors:  Howard M. Corneli
Journal:  Curr Infect Dis Rep       Date:  2004-06       Impact factor: 3.725

Review 9.  Epidemiology and prevention of valvular heart diseases and infective endocarditis in Africa.

Authors:  Vuyisile T Nkomo
Journal:  Heart       Date:  2007-12       Impact factor: 5.994

10.  The effectiveness of the McIsaac clinical decision rule in the management of sore throat: an evaluation from a pediatrics ward.

Authors:  Saravanapriya Thillaivanam; Arwa M Amin; Sheila Gopalakrishnan; Baharudin Ibrahim
Journal:  Pediatr Res       Date:  2016-05-24       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.